Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy

详细信息    查看全文

• 作者：Hooman Hosseini-Nik ; Sandra E. Fischer ; Carol-Anne E. Moulton…
• 关键词：Colorectal liver metastasis ; Chemotherapy ; Pathologic response ; Diffusion ; weighted imaging ; Gadoxetic acid ; MRI
• 刊名：Abdominal Imaging
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：41
• 期：2
• 页码：231-238
• 全文大小：1,031 KB
• 参考文献：1.Jemal A, Bray F, Center MM, et al. (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. doi:10.​3322/​caac.​20107 CrossRef PubMed
  2.Registry of Hepatic Metastases (1988) Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 103(3):278–288PubMedCentral
  3.Shah SA, Bromberg R, Coates A, et al. (2007) Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg 205(5):676–683. doi:10.​1016/​j.​jamcollsurg.​2007.​06.​283 CrossRef PubMed
  4.Kelly C, Cassidy J (2007) Chemotherapy in metastatic colorectal cancer. Surg Oncol 16(1):65–70. doi:10.​1016/​j.​suronc.​2007.​04.​006 CrossRef PubMed
  5.Kemeny N (2007) Presurgical chemotherapy in patients being considered for liver resection. Oncologist 12(7):825–839. doi:10.​1634/​theoncologist.​12-7-825 CrossRef PubMed
  6.Nordlinger B, Sorbye H, Glimelius B, et al. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371(9617):1007–1016. doi:10.​1016/​S0140-6736(08)60455-9 PubMedCentral CrossRef PubMed
  7.Chung WS, Park MS, Shin SJ, et al. (2012) Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria. AJR Am J Roentgenol 199(4):809–815. doi:10.​2214/​AJR.​11.​7910 CrossRef PubMed
  8.Quan D, Gallinger S, Nhan C, et al. (2012) The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery 151(6):860–870. doi:10.​1016/​j.​surg.​2011.​12.​018 CrossRef PubMed
  9.Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247. doi:10.​1016/​j.​ejca.​2008.​10.​026 CrossRef PubMed
  10.Grothey A, Hedrick EE, Mass RD, et al. (2008) Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107. J Clin Oncol 26(2):183–189. doi:10.​1200/​JCO.​2007.​13.​8099 CrossRef PubMed
  11.Neumann UP, Thelen A, Rocken C, et al. (2009) Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases. Surgery 146(1):52–59. doi:10.​1016/​j.​surg.​2009.​02.​004 CrossRef PubMed
  12.Rubbia-Brandt L, Giostra E, Brezault C, et al. (2007) Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 18(2):299–304. doi:10.​1093/​annonc/​mdl386 CrossRef PubMed
  13.Ramos E, Valls C, Martinez L, et al. (2011) Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Ann Surg Oncol 18(9):2654–2661. doi:10.​1245/​s10434-011-1670-y CrossRef PubMed
  14.Bischof DA, Clary BM, Maithel SK, Pawlik TM (2013) Surgical management of disappearing colorectal liver metastases. Br J Surg 100(11):1414–1420. doi:10.​1002/​bjs.​9213 CrossRef PubMed
  15.Padhani AR, Liu G, Koh DM, et al. (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11(2):102–125PubMedCentral CrossRef PubMed
  16.Koh DM, Collins DJ, Wallace T, Chau I, Riddell AM (2012) Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Br J Radiol 85(1015):980–989. doi:10.​1259/​bjr/​91771639 PubMedCentral CrossRef PubMed
  17.Chen L, Zhang J, Zhang L, et al. (2012) Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One 7(11):e48681. doi:10.​1371/​journal.​pone.​0048681 PubMedCentral CrossRef PubMed
  18.Kim A, Lee CH, Kim BH, et al. (2012) Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a “defect” on the hepatobiliary phase. Eur J Radiol 81(12):3998–4004. doi:10.​1016/​j.​ejrad.​2012.​03.​032 CrossRef PubMed
  19.Cui Y, Zhang XP, Sun YS, Tang L, Shen L (2008) Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 248(3):894–900. doi:10.​1148/​radiol.​2483071407 CrossRef PubMed
  20.Dawson R (2011) How Significant Is A Boxplot Outlier? Journal of Statistics Education 19(2):1–13
  21.Chun YS, Vauthey JN (2007) Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 33(Suppl 2):S52–S58. doi:10.​1016/​j.​ejso.​2007.​09.​026 CrossRef PubMed
  22.Adam R, De Gramont A, Figueras J, et al. (2012) The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 17(10):1225–1239. doi:10.​1634/​theoncologist.​2012-0121 PubMedCentral CrossRef PubMed
  23.Adam R, Vinet E (2004) Regional treatment of metastasis: surgery of colorectal liver metastases. Ann Oncol 4:103–106. doi:10.​1093/​annonc/​mdh912
  24.Nordlinger B, Van Cutsem E, Rougier P, et al. (2007) Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer 43(14):2037–2045. doi:10.​1016/​j.​ejca.​2007.​07.​017 CrossRef PubMed
  25.Folprecht G, Gruenberger T, Bechstein WO, et al. (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 11(1):38–47. doi:10.​1016/​S1470-2045(09)70330-4 CrossRef PubMed
  26.Adam R, Delvart V, Pascal G, et al. (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240(4):644–657 (discussion 657–648)PubMedCentral PubMed
  27.Simmonds PC, Primrose JN, Colquitt JL, et al. (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94(7):982–999. doi:10.​1038/​sj.​bjc.​6603033 PubMedCentral CrossRef PubMed
  28.Chun YS, Vauthey JN, Boonsirikamchai P, et al. (2009) Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302(21):2338–2344. doi:10.​1001/​jama.​2009.​1755 PubMedCentral CrossRef PubMed
  29.Egger ME, Cannon RM, Metzger TL, et al. (2013) Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg 216(4):845–856 (discussion 856–847). doi:10.​1016/​j.​jamcollsurg.​2012.​12.​037 CrossRef PubMed
  30.Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52–60. doi:10.​1055/​s-0030-1247132 CrossRef PubMed
  31.Ha S, Lee CH, Kim BH, et al. (2012) Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the “target sign” a common finding? Magn Reson Imaging 30(8):1083–1090. doi:10.​1016/​j.​mri.​2012.​03.​007 CrossRef PubMed
  32.Milot L, Guindi M, Gallinger S, et al. (2010) MR imaging correlates of intratumoral tissue types within colorectal liver metastases: a high-spatial-resolution fresh ex vivo radiologic-pathologic correlation study. Radiology 254(3):747–754. doi:10.​1148/​radiol.​09090508 CrossRef PubMed
  33.Outwater E, Tomaszewski JE, Daly JM, Kressel HY (1991) Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. Radiology 180(2):327–332CrossRef PubMed
  34.Muramatsu Y, Takayasu K, Moriyama N, et al. (1986) Peripheral low-density area of hepatic tumors: CT-pathologic correlation. Radiology 160(1):49–52. doi:10.​1148/​radiology.​160.​1.​3012632 CrossRef PubMed
  
• 作者单位：Hooman Hosseini-Nik (1)
  Sandra E. Fischer (2)
  Carol-Anne E. Moulton (3)
  Gautam Karbhase (1)
  Ravi J. Menezes (4)
  Steven Gallinger (3)
  Kartik S. Jhaveri (4)
  
  1. Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women’s College Hospital, Toronto, ON, Canada
  2. Department of Pathology, University Health Network, University of Toronto, Toronto, ON, Canada
  3. Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada
  4. Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, ON, Canada
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Imaging and Radiology
  Gastroenterology
  Hepatology
  
• 出版者：Springer New York
• ISSN：1432-0509

文摘

Purpose To evaluate the diagnostic performance of diffusion-weighted imaging (DWI) and gadoxetic acid-enhanced magnetic resonance imaging (MRI) to differentiate colorectal liver metastasis (CRLM) with complete pathologic response from those with incomplete response in patients treated with preoperative chemotherapy.